HC Wainwright Reiterates “Buy” Rating for Atyr PHARMA (NASDAQ:ATYR)
Atyr PHARMA (NASDAQ:ATYR – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $35.00 price objective on the stock. Other equities research analysts also recently issued reports about the company. Leerink Partners […]
Atyr PHARMA (NASDAQ:ATYR – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $35.00 price objective on the stock. Other equities research analysts also recently issued reports about the company. Leerink Partners […]
